Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Tapentadol

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 519Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Karnataka Launches Online Tracking For Tapentadol Sales
    Karnataka Launches Online Tracking For Tapentadol Sales

    20 Sep 2024

    // PHARMABIZ

    https://www.pharmabiz.com/NewsDetails.aspx?aid=172552&sid=1

    PHARMABIZ
    20 Sep 2024
    Share Share
    Collegium Obtains Six Month Extension of U.S. Pediatric Exclusivity for Nucynta
    Collegium Obtains Six Month Extension of U.S. Pediatric Exclusivity for Nucynta

    13 Jun 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/06/13/2898220/34897/en/Collegium-Obtains-Six-Month-Extension-of-U-S-Pediatric-Exclusivity-for-Nucynta-Franchise.html

    GLOBENEWSWIRE
    13 Jun 2024
    Share Share
    Two painkillers Tapentadol and Pregabalin may go off OTC over misuse
    Two painkillers Tapentadol and Pregabalin may go off OTC over misuse

    25 Nov 2023

    // ECONOMIC TIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/two-painkillers-tapentadol-and-pregabalin-may-go-off-otc-over-misuse/articleshow/105482448.cms

    ECONOMIC TIMES
    25 Nov 2023
    Share Share
    Alkem's Generic Tapentadol Receives Approval in the U.S.
    Alkem's Generic Tapentadol Receives Approval in the U.S.

    07 Jul 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205016

    FDA
    07 Jul 2023
    Share Share
    Recall of Palexia® oral solution 20mg/ml and Palexia® 4 mg/ml oral solution
    Recall of Palexia® oral solution 20mg/ml and Palexia® 4 mg/ml oral solution

    08 Feb 2021

    // PRESS RELEASE

    https://www.grunenthal.com/en/press-room/statements/media-statement-recall-of-palexia-oral-solution

    PRESS RELEASE
    08 Feb 2021
    Share Share
    Restrict use of pain reliever Tapentadol: Child rights panel urges government
    Restrict use of pain reliever Tapentadol: Child rights panel urges government

    08 Sep 2020

    // T. Thacker ECONOMIC TIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/restrict-use-of-pain-reliever-tapentadol-child-rights-panel-urges-government/articleshow/78009939.cms

    T. Thacker ECONOMIC TIMES
    08 Sep 2020
    Share Share